It was this theme, the importance of equity in digital health, that I spoke about at the Cambridge Wearable Innovation Forum ...

Dr. Khoury is the founding Director of the Office of Public Health Genomics at the U.S. Centers for Disease Control and Prevention. The Office was formed in 1998 and Dr Khoury served as the only ...

Zoë Fritz is an Associate Professor in Medical Ethics and Ageing based in THIS Institute and a Consultant Physician in Acute Medicine at Addenbrooke’s Hospital. Her research is focused on identifying ...

We are an exempt charity under the Charities Act 2011 and regulated by the Office for Students (OFS) as a connected institution of the University of Cambridge. We are also a registered company no.

Mike grew up in the Seattle area before beginning undergraduate study in 1999 at the University of Washington, where he graduated with BSc’s in biochemistry and economics. As a 19 year-old, Mike began ...

Colin is the PHG Foundation’s Head of Humanities. He leads the team’s work on legal and ethical issues across genomics, novel health technologies, innovative biomedical research and data. Some key ...

A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI). The MHRA proposed new five-year ...

These plans have been a long time in the making. The intention to produce a strategy ‘to ensure the UK is able to offer a predictive, preventative and personalised health and care service for people ...

A new report from the House of Commons Science and Technology Committee sets out recommendations for the UK Government needed, the committee says, to ensure that the transformative potential of ...

The rapid development, approval and roll out of multiple vaccines against SARS-CoV-2, the virus that causes COVID-19, is an impressive achievement for science and healthcare. The virus genome was ...

Cost-utility studies provide critical information for the costs and benefits of using any new test, typically building on existing public health and screening programmes, within a defined population.